New prostate cancer test ‘more specific’ than conventional PSA test
Submitted by Mohit Joshi on Tue, 05/17/2011 - 10:43
Washington, May 17: A study by researchers at UCLA''s Jonsson Comprehensive Cancer Center has suggested that a new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today.
Prostate cancer survival rates can be extended to 20 yrs with surgery
Submitted by Mohit Joshi on Mon, 05/16/2011 - 11:11
Washington, May 16 : Mayo clinic researchers have found that 80 percent of patients diagnosed with cancer that has spread beyond the prostate, known as cT3 prostate cancer patients, has 20 years survival rate if treated with radical prostatectomy, or surgery to remove the prostate gland.
Losing hair at 20 linked to increased risk of prostate cancer
Submitted by Mohit Joshi on Wed, 02/16/2011 - 10:12Washington, Feb 16: A French study has found that men who start to lose hair at the age of 20 are more likely to develop prostate cancer in later life.
The research compared 388 men being treated for prostate cancer with a control group of 281 healthy men and found that those with the disease were twice as likely as the healthy men to have started going bald when they were 20.
Simple test could save prostate cancer patients from surgery
Submitted by Mohit Joshi on Wed, 02/09/2011 - 22:58
London, Feb 9 : Scientists say that a simple test could save thousands of prostate cancer patients from operation.
Research has shown men with certain genes are three times more likely to have the most dangerous form. While these patients need surgery, those without these genes are less likely to see their tumours grow quickly and may be able to avoid surgery altogether.
Baldness at young age cuts prostate cancer risk
Submitted by Mohit Joshi on Tue, 03/16/2010 - 20:35
London, March 16 : Men who go bald at an early age have less chances of suffering from prostate cancer, according to a new study.
An American team observed 2,000 men aged between 40 and 47, half of whom had prostate cancer.
It was learnt that those who had their hair thinned by the age of 30 were 45 per cent less likely to get prostrate cancer, compared to those who did not suffer hair loss.
Mediterranean-style diet may help prevent prostate cancer
Submitted by Mohit Joshi on Sat, 02/14/2009 - 11:13
Washington, Feb 14: The traditional Cretan Mediterranean-style diet, based on a variety of plant foods, may help prevent prostate cancer, according to a review.
The researchers showed that dietary intake of fruits, vegetables, wholegrain cereals, nuts and legumes along with olive oil as the main source of fat may provide protection against cancer.
Sex, masturbation linked to prostate cancer risk
Submitted by Mohit Joshi on Tue, 01/27/2009 - 15:16
Washington, Jan 27 : Men who are very sexually active in their 20s and 30s run a higher risk of prostate cancer, suggests a new study.
The study of more than 800 men, led by the University of Nottingham, also found that frequent sexual activity in a man''s forties appears to have little effect and if done in fifties it could in fact offer protection from the disease.
Study shows herbal supplement’s effectiveness against prostate cancer
Submitted by Mohit Joshi on Tue, 01/13/2009 - 13:00
Washington, January 13: Experiments conducted in laboratories have raised US scientists'' hopes that herbal supplement can be helpful in fighting prostate cancer.
Cough medicine ingredient could prove effective in prostate cancer treatment
Submitted by Mohit Joshi on Sat, 12/20/2008 - 11:28Washington, Dec 20: An ingredient present in a common cough suppressant has been found to be effective in the treatment of advanced prostate cancer, according to a new study.
The collaborative study revealed that noscapine, which has been used in cough medication for nearly 50 years, reduced tumour growth in mice by 60 percent and limited the spread of tumours by 65 percent without causing harmful side effects.
While prostate cancer is slow growing in most men, it is considered advanced when it spreads beyond the prostate. There is no known cure.
Combo therapy cuts prostate cancer death rate by half
Submitted by Mohit Joshi on Tue, 12/16/2008 - 15:05
London, Dec 16 : Adding radiation therapy to standard drug treatment can cut prostate cancer death rate by half, according to a new study.
Researchers said that the effects are so striking that radiotherapy combined with hormonal (drug) treatment should be the new standard for these patients, reports the Independent.
